X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,434 | 560 | 563 | 0 | 0 |
| Cost of Goods | 302 | 227 | 268 | N/A | N/A |
| Gross Profit | 1,132 | 333 | 295 | N/A | N/A |
| Operating Expenses | 37,149 | 35,060 | -70,540 | 37,289 | 25,199 |
| Operating Income | -35,715 | -34,500 | 71,103 | -37,289 | -25,199 |
| Interest Expense | 2,304 | 2,414 | 2,176 | 1,874 | 1,886 |
| Other Income | -1,544 | 233 | 21,924 | -12,584 | 7,988 |
| Pre-tax Income | -39,563 | -36,681 | 90,851 | -51,747 | -19,097 |
| Income Tax | 258 | 15 | 18 | 19 | 33 |
| Net Income Continuous | -39,821 | -36,696 | 90,833 | -51,766 | -19,130 |
| Net Income | $-39,821 | $-36,696 | $90,833 | $-51,766 | $-19,130 |
| EPS Basic Total Ops | -5.93 | -5.48 | 13.59 | -7.77 | -2.06 |
| EPS Basic Continuous Ops | -5.94 | -5.48 | 13.60 | -7.77 | -1.86 |
| EPS Diluted Total Ops | -5.91 | -5.48 | 13.57 | -7.77 | -2.06 |
| EPS Diluted Continuous Ops | -5.91 | -5.48 | 13.57 | -7.77 | -1.86 |
| EPS Diluted Before Non-Recurring Items | -6.01 | -5.41 | -2.10 | N/A | N/A |
| EBITDA(a) | $-35,442 | $-34,233 | $71,297 | $-37,227 | $-25,137 |